Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.
高成長
同社の収益は過去3年間にわたり着実に増加しており、年平均で85.29%の成長率を示しています。
成長中
同社は成長フェーズにあり、最新の年間収益はUSD 819.00Kに達しています。
割安
同社の最新のPEは-0.08で、過去3年間の水準と比較して安値圏にあります。
機関投資家の買い増し
最新の機関投資家の保有株数は304.48K株で、前四半期比で43.06%増加しています。
市場活動が活発
同社への投資家の関心が高まっており、20日間の売買回転率は6.93です。